Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 232
Filter
1.
J Neurochem ; 157(6): 2008-2023, 2021 06.
Article in English | MEDLINE | ID: mdl-33638175

ABSTRACT

N-acetylaspartylglutamate (NAAG) is an abundant neuropeptide in the mammalian nervous system, synthesized by two related NAAG synthetases I and II (NAAGS-I and -II) encoded by the genes Rimklb and Rimkla, respectively. NAAG plays a role in cognition and memory, according to studies using inhibitors of the NAAG hydrolase glutamate carboxypeptidase II that increase NAAG concentration. To examine consequences of reduced NAAG concentration, Rimkla-deficient (Rimkla-/- ) mice were generated. These mice exhibit normal NAAG level at birth, likely because of the intact Rimklb gene, but have significantly reduced NAAG levels in all brain regions in adulthood. In wild type mice NAAGS-II was most abundant in brainstem and spinal cord, as demonstrated using a new NAAGS-II antiserum. In the hippocampus, NAAGS-II was only detectable in neurons expressing parvalbumin, a marker of GABAergic interneurons. Apart from reduced open field activity, general behavior of adult (6 months old) Rimkla-/- mice examined in different tests (dark-light transition, optokinetic behavior, rotarod, and alternating T-maze) was not significantly altered. However, Rimkla-/- mice were impaired in a short-term novel object recognition test. This was also the case for mice lacking NAA synthase Nat8l, which are devoid of NAAG. Together with results from previous studies showing that inhibition of the NAAG degrading enzyme glutamate carboxypeptidase II is associated with a significant improvement in object recognition, these results suggest a direct involvement of NAAG synthesized by NAAGS-II in the memory consolidation underlying the novel object recognition task.


Subject(s)
Dipeptides/deficiency , Dipeptides/genetics , Ligases/deficiency , Ligases/genetics , Maze Learning/physiology , Recognition, Psychology/physiology , Animals , Glutamate Carboxypeptidase II/deficiency , Glutamate Carboxypeptidase II/genetics , Male , Mice , Mice, Inbred C57BL , Mice, Transgenic
2.
EBioMedicine ; 55: 102761, 2020 May.
Article in English | MEDLINE | ID: mdl-32361249

ABSTRACT

BACKGROUND: Human tuberculosis (TB) is caused by a plethora of Mycobacterium tuberculosis complex (MTBC) strains belonging to seven phylogenetic branches. Lineages 2, 3 and 4 are considered "modern" branches of the MTBC responsible for the majority of worldwide TB. Since the current BCG vaccine confers variable protection against pulmonary TB, new candidates are investigated. MTBVAC is the unique live attenuated vaccine based on M. tuberculosis in human clinical trials. METHODS: MTBVAC was originally constructed by unmarked phoP and fadD26 deletions in a clinical isolate belonging to L4. Here we construct new vaccines based on isogenic gene deletions in clinical isolates of the L2 and L3 modern lineages. These three vaccine candidates were characterized at molecular level and also in animal experiments of protection and safety. FINDINGS: Safety studies in immunocompromised mice showed that MTBVAC-L2 was less attenuated than BCG Pasteur, while the original MTBVAC was found even more attenuated than BCG and MTBVAC-L3 showed an intermediate phenotype. The three MTBVAC candidates showed similar or superior protection compared to BCG in immunocompetent mice vaccinated with each MTBVAC candidate and challenged with three representative strains of the modern lineages. INTERPRETATION: MTBVAC vaccines, based on double phoP and fadD26 deletions, protect against TB independently of the phylogenetic linage used as template strain for their construction. Nevertheless, lineage L4 confers the best safety profile. FUNDING: European Commission (TBVAC2020, H2020-PHC-643381), Spanish Ministry of Science (RTI2018-097625-B-I00), Instituto de Salud Carlos III (PI18/0336), Gobierno de Aragón/Fondo Social Europeo and the French National Research Council (ANR-10-LABX-62-IBEID, ANR-16-CE35-0009, ANR-16-CE15-0003).


Subject(s)
Bacterial Proteins/immunology , Ligases/immunology , Mycobacterium tuberculosis/immunology , Tuberculosis Vaccines/administration & dosage , Tuberculosis, Pulmonary/genetics , Tuberculosis, Pulmonary/prevention & control , Animals , BCG Vaccine/administration & dosage , BCG Vaccine/biosynthesis , BCG Vaccine/genetics , Bacterial Proteins/genetics , Female , Gene Deletion , Gene Expression , Genetic Background , Humans , Immunogenicity, Vaccine , Ligases/deficiency , Ligases/genetics , Mice , Mice, SCID , Mycobacterium tuberculosis/genetics , Mycobacterium tuberculosis/pathogenicity , Patient Safety , Survival Analysis , Tuberculosis Vaccines/biosynthesis , Tuberculosis Vaccines/genetics , Tuberculosis, Pulmonary/immunology , Tuberculosis, Pulmonary/mortality , Vaccination , Vaccines, Attenuated , White People
3.
Infect Immun ; 88(1)2019 12 17.
Article in English | MEDLINE | ID: mdl-31591165

ABSTRACT

Despite the great increase in the understanding of the biology and pathogenesis of Mycobacterium tuberculosis achieved by the scientific community in recent decades, tuberculosis (TB) still represents one of the major threats to global human health. The only available vaccine (Mycobacterium bovis BCG) protects children from disseminated forms of TB but does not effectively protect adults from the respiratory form of the disease, making the development of new and more-efficacious vaccines against the pulmonary forms of TB a major goal for the improvement of global health. Among the different strategies being developed to reach this goal is the construction of attenuated strains more efficacious and safer than BCG. We recently showed that a sigE mutant of M. tuberculosis was more attenuated and more efficacious than BCG in a mouse model of infection. In this paper, we describe the construction and characterization of an M. tuberculosissigE fadD26 unmarked double mutant fulfilling the criteria of the Geneva Consensus for entering human clinical trials. The data presented suggest that this mutant is even more attenuated and slightly more efficacious than the previous sigE mutant in different mouse models of infection and is equivalent to BCG in a guinea pig model of infection.


Subject(s)
Ligases/deficiency , Mycobacterium tuberculosis/immunology , Sigma Factor/deficiency , Tuberculosis Vaccines/immunology , Tuberculosis, Pulmonary/prevention & control , Animals , Bacterial Proteins , Disease Models, Animal , Guinea Pigs , Mice , Mycobacterium tuberculosis/genetics , Mycobacterium tuberculosis/pathogenicity , Tuberculosis Vaccines/adverse effects , Tuberculosis Vaccines/genetics , Vaccines, Attenuated/adverse effects , Vaccines, Attenuated/genetics , Vaccines, Attenuated/immunology , Virulence
4.
PLoS Genet ; 15(2): e1007942, 2019 02.
Article in English | MEDLINE | ID: mdl-30735491

ABSTRACT

NSMCE2 is an E3 SUMO ligase and a subunit of the SMC5/6 complex that associates with the replication fork and protects against genomic instability. Here, we study the fate of collapsed replication forks generated by prolonged hydroxyurea treatment in human NSMCE2-deficient cells. Double strand breaks accumulate during rescue by converging forks in normal cells but not in NSMCE2-deficient cells. Un-rescued forks persist into mitosis, leading to increased mitotic DNA damage. Excess RAD51 accumulates and persists at collapsed forks in NSMCE2-deficient cells, possibly due to lack of BLM recruitment to stalled forks. Despite failure of BLM to accumulate at stalled forks, NSMCE2-deficient cells exhibit lower levels of hydroxyurea-induced sister chromatid exchange. In cells deficient in both NSMCE2 and BLM, hydroxyurea-induced double strand breaks and sister chromatid exchange resembled levels found in NSCME2-deficient cells. We conclude that the rescue of collapsed forks by converging forks is dependent on NSMCE2.


Subject(s)
DNA Damage , Ligases/metabolism , Mitosis , DNA Breaks, Double-Stranded , DNA Repair , DNA Replication , Epistasis, Genetic , Genomic Instability , HEK293 Cells , HeLa Cells , Humans , Hydroxyurea/pharmacology , Ligases/deficiency , Ligases/genetics , Models, Biological , Rad51 Recombinase/genetics , Rad51 Recombinase/metabolism , RecQ Helicases/deficiency , RecQ Helicases/genetics , RecQ Helicases/metabolism , Sister Chromatid Exchange/drug effects , Sumoylation
5.
Cell Rep ; 21(11): 3155-3165, 2017 Dec 12.
Article in English | MEDLINE | ID: mdl-29241543

ABSTRACT

The bacterial and plant stringent response involves production of the signaling molecules guanosine tetraphosphate and guanosine pentaphosphate ((p)ppGpp), leading to global reorganization of gene expression. The function of the stringent response has been well characterized in stress conditions, but its regulatory role during unstressed growth is less studied. Here, we demonstrate that (p)ppGpp-deficient strains of S. elongatus have globally deregulated biosynthetic capacity, with increased transcription rate, translation rate, and cell size in unstressed conditions in light and impaired viability in darkness. Synthetic restoration of basal guanosine tetraphosphate (ppGpp) levels is sufficient to recover transcriptional balance and appropriate cell size in light and to rescue viability in light/dark conditions, but it is insufficient to enable efficient dark-induced transcriptional shutdown. Our work underscores the importance of basal ppGpp signaling for regulation of cyanobacterial physiology in the absence of stress and for viability in energy-limiting conditions, highlighting that basal (p)ppGpp level is essential in cyanobacteria in the environmental light/dark cycle.


Subject(s)
Bacterial Proteins/genetics , Gene Expression Regulation, Bacterial , Guanosine Pentaphosphate/metabolism , Ligases/genetics , Light Signal Transduction/genetics , Synechococcus/genetics , Bacterial Proteins/metabolism , Darkness , Ligases/deficiency , Microbial Viability/radiation effects , Protein Biosynthesis , Synechococcus/metabolism , Synechococcus/radiation effects , Transcription, Genetic
6.
PLoS One ; 12(4): e0176374, 2017.
Article in English | MEDLINE | ID: mdl-28448619

ABSTRACT

Pyridoxal 5'-phosphate (PLP) is an essential cofactor for numerous enzymes involved in a diversity of cellular processes in living organisms. Previous analysis of the Actinobacillus pleuropneumoniae S-8 genome sequence revealed the presence of pdxS and pdxT genes, which are implicated in deoxyxylulose 5-phosphate (DXP)-independent pathway of PLP biosynthesis; however, little is known about their roles in A. pleuropneumoniae pathogenicity. Our data demonstrated that A. pleuropneumoniae could synthesize PLP by PdxS and PdxT enzymes. Disruption of the pdxS and pdxT genes rendered the pathogen auxotrophic for PLP, and the defective growth as a result of these mutants was chemically compensated by the addition of PLP, suggesting the importance of PLP production for A. pleuropneumoniae growth and viability. Additionally, the pdxS and pdxT deletion mutants displayed morphological defects as indicated by irregular and aberrant shapes in the absence of PLP. The reduced growth of the pdxS and pdxT deletion mutants under osmotic and oxidative stress conditions suggests that the PLP synthases PdxS/PdxT are associated with the stress tolerance of A. pleuropneumoniae. Furthermore, disruption of the PLP biosynthesis pathway led to reduced colonization and attenuated virulence of A. pleuropneumoniae in the BALB/c mouse model. The data presented in this study reveal the critical role of PLP synthases PdxS/PdxT in viability, stress tolerance, and virulence of A. pleuropneumoniae.


Subject(s)
Actinobacillus pleuropneumoniae/enzymology , Actinobacillus pleuropneumoniae/physiology , Ligases/metabolism , Microbial Viability , Pyridoxal Phosphate/biosynthesis , Stress, Physiological , Actinobacillus pleuropneumoniae/genetics , Actinobacillus pleuropneumoniae/pathogenicity , Animals , Female , Gene Knockout Techniques , Hydrogen Peroxide/pharmacology , Ligases/deficiency , Ligases/genetics , Mice , Mice, Inbred BALB C , Mutation , Sodium Chloride/pharmacology , Virulence
7.
Sci Rep ; 7: 43320, 2017 03 03.
Article in English | MEDLINE | ID: mdl-28256553

ABSTRACT

CRISPR/Cas9 is a powerful genome editing tool that has been extensively used in model plants and crops, such as Arabidopsis thaliana, rice, wheat, and soybean. Here, we report the use of CRISPR/Cas9 to precisely knock out the committed diterpene synthase gene (SmCPS1) involved in tanshinone biosynthesis in Salvia miltiorrhiza, a traditional Chinese medicinal herb with significant pharmacological activities, such as vasorelaxation, protection against ischemia-reperfusion injury, and antiarrhythmic effects. Three homozygous and eight chimeric mutants were obtained from 26 independent transgenic hairy root lines by Agrobacterium rhizogenes-mediated transformation. The metabolomic analysis based on LC-qTOF-MS and Q-TRAP-LC-MS/MS revealed that tanshinones, especially cryptotanshinone, tanshinone IIA and tanshinone I, are completely missing in homozygous mutants, without influencing other phenolic acid metabolites. By contrast, tanshinones are decreased but still detectable in chimeric mutants, which is similar to a previously-reported an RNAi study of SmCPS1. These results demonstrate that Agrobacterium rhizogenes- mediated transformation using CRISPR/Cas9 is a simple and efficient genome editing tool in S. miltiorrhiza, thus paving the way for large-scale genome editing in S. miltiorrhiza, which is important for pathway elucidation of secondary metabolites, quality improvement, and yield increases for this valuable traditional Chinese medicinal herb.


Subject(s)
CRISPR-Cas Systems , Genome, Plant , Ligases/genetics , Plant Proteins/genetics , Plant Roots/genetics , Salvia miltiorrhiza/genetics , Abietanes , Agrobacterium/genetics , Agrobacterium/metabolism , Base Sequence , Diterpenes/metabolism , Gene Editing/methods , Gene Expression Regulation, Plant , Gene Knockout Techniques , Hydroxybenzoates/metabolism , Ligases/deficiency , Mutagenesis , Phenanthrenes , Plant Proteins/metabolism , Plant Roots/metabolism , Plants, Medicinal , Salvia miltiorrhiza/metabolism , Sequence Alignment
8.
Sci Rep ; 6: 27045, 2016 05 31.
Article in English | MEDLINE | ID: mdl-27244565

ABSTRACT

Streptomycetes are filamentous bacteria that produce numerous valuable compounds, including the majority of clinically used antibiotics. At an industrial scale, most of these compounds are produced in bioreactors. Growth of streptomycetes under these conditions is characterized by the formation of complex mycelial particles, whose sizes follow a bimodal distribution. Given the correlation between specific productivity and morphology, this size heterogeneity poses a potential drawback in industry. Recent work indicates that mycelial morphology is controlled by a number of genes that encode proteins required for the synthesis of cell surface-associated glycans. Using a quantifiable system based on fluorescent markers, we here show that these glycans mediate aggregation between germlings and young mycelia, yielding mycelial particles that originate from many different individuals. We also demonstrate that at later time points aggregation between distinct particles is no longer detectable. Notably, the absence of the corresponding glycan synthases yields mycelia that are homogeneous in size, identifying mycelial aggregation as a driving factor towards size heterogeneity. Given that aggregation is widespread within streptomycetes and can also occur between different Streptomyces strains, our work paves the way to improve Streptomyces as a cell factory for the production of known metabolites, but possibly also to discover new ones.


Subject(s)
Gene Deletion , Industrial Microbiology/methods , Ligases/deficiency , Mycelium/genetics , Streptomyces/genetics , Bacterial Proteins/genetics , Bacterial Proteins/metabolism , Bioreactors , Fermentation , Flocculation , Gene Expression , Genes, Reporter , Genetic Heterogeneity , Green Fluorescent Proteins/genetics , Green Fluorescent Proteins/metabolism , Ligases/genetics , Luminescent Proteins/genetics , Luminescent Proteins/metabolism , Metabolic Engineering , Mycelium/metabolism , Mycelium/ultrastructure , Polysaccharides, Bacterial/biosynthesis , Streptomyces/metabolism , Streptomyces/ultrastructure , Red Fluorescent Protein
9.
Biochemistry ; 55(17): 2510-7, 2016 05 03.
Article in English | MEDLINE | ID: mdl-27015018

ABSTRACT

ß-Toxin is an important virulence factor of Staphylococcus aureus, contributing to colonization and development of disease [Salgado-Pabon, W., et al. (2014) J. Infect. Dis. 210, 784-792; Huseby, M. J., et al. (2010) Proc. Natl. Acad. Sci. U.S.A. 107, 14407-14412; Katayama, Y., et al. (2013) J. Bacteriol. 195, 1194-1203]. This cytotoxin has two distinct mechanisms of action: sphingomyelinase activity and DNA biofilm ligase activity. However, the distinct mechanism that is most important for its role in infective endocarditis is unknown. We characterized the active site of ß-toxin DNA biofilm ligase activity by examining deficiencies in site-directed mutants through in vitro DNA precipitation and biofilm formation assays. Possible conformational changes in mutant structure compared to that of wild-type toxin were assessed preliminarily by trypsin digestion analysis, retention of sphingomyelinase activity, and predicted structures based on the native toxin structure. We addressed the contribution of each mechanism of action to producing infective endocarditis and sepsis in vivo in a rabbit model. The H289N ß-toxin mutant, lacking sphingomyelinase activity, exhibited lower sepsis lethality and infective endocarditis vegetation formation compared to those of the wild-type toxin. ß-Toxin mutants with disrupted biofilm ligase activity did not exhibit decreased sepsis lethality but were deficient in infective endocarditis vegetation formation compared to the wild-type protein. Our study begins to characterize the DNA biofilm ligase active site of ß-toxin and suggests ß-toxin functions importantly in infective endocarditis through both of its mechanisms of action.


Subject(s)
Bacterial Toxins/adverse effects , Biofilms/drug effects , Endocarditis/etiology , Hemolysin Proteins/adverse effects , Ligases/deficiency , Sepsis/etiology , Sphingomyelin Phosphodiesterase/deficiency , Staphylococcus aureus/enzymology , Amino Acid Sequence , Animals , Bacterial Toxins/chemistry , Bacterial Toxins/genetics , Bacterial Toxins/metabolism , Biofilms/growth & development , Endocarditis/enzymology , Endocarditis/pathology , Female , Hemolysin Proteins/chemistry , Hemolysin Proteins/genetics , Hemolysin Proteins/metabolism , Male , Protein Conformation , Rabbits , Sepsis/enzymology , Sepsis/pathology , Sphingomyelin Phosphodiesterase/adverse effects , Sphingomyelin Phosphodiesterase/chemistry , Sphingomyelin Phosphodiesterase/genetics , Sphingomyelin Phosphodiesterase/metabolism , Staphylococcal Infections/complications , Staphylococcal Infections/microbiology , Staphylococcus aureus/genetics
10.
PLoS One ; 9(9): e106938, 2014.
Article in English | MEDLINE | ID: mdl-25188023

ABSTRACT

In Escherichia coli, ppGpp is a major determinant of growth and glycogen accumulation. Levels of this signaling nucleotide are controlled by the balanced activities of the ppGpp RelA synthetase and the dual-function hydrolase/synthetase SpoT. Here we report the construction of spoT null (ΔspoT) mutants obtained by transducing a ΔspoT allele from ΔrelAΔspoT double mutants into relA+ cells. Iodine staining of randomly selected transductants cultured on a rich complex medium revealed differences in glycogen content among them. Sequence and biochemical analyses of 8 ΔspoT clones displaying glycogen-deficient phenotypes revealed different inactivating mutations in relA and no detectable ppGpp when cells were cultured on a rich complex medium. Remarkably, although the co-existence of ΔspoT with relA proficient alleles has generally been considered synthetically lethal, we found that 11 ΔspoT clones displaying high glycogen phenotypes possessed relA mutant alleles with non-inactivating mutations that encoded stable RelA proteins and ppGpp contents reaching 45-85% of those of wild type cells. None of the ΔspoT clones, however, could grow on M9-glucose minimal medium. Both Sanger sequencing of specific genes and high-throughput genome sequencing of the ΔspoT clones revealed that suppressor mutations were restricted to the relA locus. The overall results (a) defined in around 4 nmoles ppGpp/g dry weight the threshold cellular levels that suffice to trigger net glycogen accumulation, (b) showed that mutations in relA, but not necessarily inactivating mutations, can be selected to compensate total SpoT function(s) loss, and (c) provided useful tools for studies of the in vivo regulation of E. coli RelA ppGpp synthetase.


Subject(s)
Escherichia coli/genetics , Gene Expression Regulation, Bacterial , Glycogen/genetics , Ligases/genetics , Pyrophosphatases/genetics , Suppression, Genetic , Alleles , Amino Acid Sequence , Clone Cells , Escherichia coli/metabolism , Genetic Loci , Genotype , Glycogen/metabolism , Ligases/deficiency , Molecular Sequence Data , Phenotype , Pyrophosphatases/deficiency , Sequence Alignment , Transduction, Genetic
11.
Yi Chuan ; 36(4): 346-53, 2014 Apr.
Article in Chinese | MEDLINE | ID: mdl-24846979

ABSTRACT

In this study, the roles of hMMS2 (human methyl methanesulfonate sensitive mutant 2) gene encoding the human ubiquitin-conjugating enzyme E2 variant 2 in the drug resistance in human colon carcinoma were investigated by using a well-differentiated human colorectal carcinoma L-OHP-resistant cell line, THC8307/L-OHP. THC8307/L-OHP cells were transfected via liposome along with plasmid pcDNA6.2-GW/EmGFP-miR-MMS2 expressing both miRNA against hMMS2 and GFP, followed by real-time fluorescent quantitative PCR and immunofluorescence to select stable transfectants with significantly reduced hMMS2 expression. Compared with untransfected or pcDNA6.2-GW/EmGFP vector-transfected cells, the hMMS2-depleted cells displayed significantly (P<0.05) reduced half inhibition concentration(IC50) resistance index (RI) and colony-forming efficiency (CFE) upon treatment with oxaliplatin (L-OHP), while its relative reverse efficiency(RRE) was significantly higher (P<0.05) than the control cells, indicating compromised ability of cell proliferation. Indeed, Rho-damine 123 staining and flow cytometry analyses revealed an increased rate of apoptosis in hMMS2-depleted cells while no difference in cell proliferation or apoptosis was observed between the two control cell lines. The above observations collec-tively indicate that suppression of hMMS2 reverses L-OHP tolerance in differentiated human colorectal carcinoma cells by promoting apoptosis.


Subject(s)
Colonic Neoplasms/pathology , Drug Resistance, Neoplasm/genetics , Ligases/genetics , Organoplatinum Compounds/pharmacology , Apoptosis/drug effects , Apoptosis/genetics , Cell Line, Tumor , Cell Nucleus/drug effects , Cell Nucleus/genetics , Cell Proliferation/drug effects , Colonic Neoplasms/genetics , Gene Expression Regulation, Neoplastic/drug effects , Gene Expression Regulation, Neoplastic/genetics , Gene Silencing , Humans , Ligases/deficiency , Oxaliplatin , RNA, Small Interfering/genetics , Sequence Analysis, RNA , Ubiquitin-Conjugating Enzymes
12.
PLoS One ; 9(3): e91703, 2014.
Article in English | MEDLINE | ID: mdl-24643076

ABSTRACT

Enteropathogenic Escherichia coli (EPEC) is a known causative agent of diarrhea in children. In the process of colonization of the small intestine, EPEC synthesizes two types of adhesins, the bundle-forming pilus (BFP) and intimin. The BFP pilus is an adhesin associated with the initial stages of adherence of EPEC to epithelial cells, while the outer membrane protein intimin carries out the intimate adherence that takes place at the third stage of infection. BFP is encoded by the bfp operon located in plasmid EAF, present only in typical EPEC isolates, while eae, the gene that encodes intimin is situated in the LEE, a chromosomal pathogenicity island. Transcription of bfp and eae is regulated by the products of the perABC operon, also present in plasmid EAF. Here we show that deletion of relA, that encodes a guanosine penta and tetraphosphate synthetase impairs EPEC adherence to epithelial cells in vitro. In the absence of relA, the transcription of the regulatory operon perABC is reduced, resulting in lower levels of BFP and intimin. Bacterial adherence, BFP and intimin synthesis and perABC expression are restored upon complementation with the wild-type relA allele.


Subject(s)
Adhesins, Bacterial/genetics , Enteropathogenic Escherichia coli/genetics , Escherichia coli Proteins/genetics , Fimbriae Proteins/genetics , Gene Expression Regulation, Bacterial , Ligases/genetics , Protein Subunits/genetics , Adhesins, Bacterial/metabolism , Bacterial Adhesion , Enteropathogenic Escherichia coli/metabolism , Enteropathogenic Escherichia coli/pathogenicity , Escherichia coli Proteins/metabolism , Fimbriae Proteins/metabolism , Gene Deletion , Genetic Complementation Test , Genomic Islands , Ligases/deficiency , Operon , Protein Subunits/metabolism
13.
Antimicrob Agents Chemother ; 57(11): 5710-3, 2013 Nov.
Article in English | MEDLINE | ID: mdl-23959312

ABSTRACT

In this study, we attempted to adopt the auxotrophic mevalonate synthase mutant (ΔmvaS mutant) of Staphylococcus aureus to study whether a nongrowing but viable cell population is tolerant to bactericidal antibiotics. The mevalonate-depleted nongrowing ΔmvaS mutant was found tolerant to antibiotics. Surprisingly, after prolonged cultivation, we obtained stable ΔmvaS variants that were able to grow without mevalonate, which suggested unknown mechanisms for compensating undecaprenyl pyrophosphate production without mevalonate in S. aureus.


Subject(s)
Adaptation, Physiological , Bacterial Proteins/genetics , Ligases/genetics , Mevalonic Acid/metabolism , Staphylococcus aureus/metabolism , Anti-Bacterial Agents/pharmacology , Bacterial Proteins/metabolism , Ciprofloxacin/pharmacology , Colony Count, Microbial , Daptomycin/pharmacology , Gene Deletion , Genetic Complementation Test , Gentamicins/pharmacology , Ligases/deficiency , Microbial Sensitivity Tests , Polyisoprenyl Phosphates/metabolism , Rifampin/pharmacology , Staphylococcus aureus/drug effects , Staphylococcus aureus/genetics , Staphylococcus aureus/growth & development
14.
PLoS One ; 8(5): e63394, 2013.
Article in English | MEDLINE | ID: mdl-23704903

ABSTRACT

Burkholderia pseudomallei is a Gram-negative environmental bacterium and the causative agent of melioidosis, a potentially fatal, acute or chronic disease endemic in the tropics. Acyl homoserine lactone (AHL)-mediated quorum sensing and signalling have been associated with virulence and biofilm formation in numerous bacterial pathogens. In the canonical acyl-homoserine lactone signalling paradigm, AHLs are detected by a response regulator. B. pseudomallei encodes three AHL synthases, encoded by bpsI1, bpsI2 and bpsI3, and five regulator genes. In this study, we mutated the B. pseudomallei AHL synthases individually and in double and triple combination. Five AHLs were detected and quantified by tandem liquid chromatography-mass spectroscopy. The major AHLs produced were N-octanoylhomoserine lactone and N-(3-hydroxy-decanoyl)homoserine lactone, the expression of which depended on bpsI1 and bpsI2, respectively. B. pseudomallei infection of macrophage cells causes cell fusion, leading to multinucleated cells (3 or more nuclei per cell). A triple mutant defective in production of all three AHL synthases was associated with a striking phenotype of massively enhanced host cellular fusion in macrophages. However, neither abrogation of host cell fusion, achieved by mutation of bimA or hcp1, nor enhancement of fusion altered intracellular replication of B. pseudomallei. Furthermore, when tested in murine models of acute melioidosis the AHL synthase mutants were not attenuated for virulence. Collectively, this study identifies important new aspects of the genetic basis of AHL synthesis in B. pseudomallei and the roles of these AHLs in systemic infection and in cell fusion in macrophages for this important human pathogen.


Subject(s)
Burkholderia pseudomallei/growth & development , Giant Cells/pathology , Intracellular Space/microbiology , Macrophages/microbiology , Macrophages/pathology , Quorum Sensing , Acyl-Butyrolactones/metabolism , Administration, Intranasal , Animals , Burkholderia pseudomallei/genetics , Burkholderia pseudomallei/pathogenicity , Cell Line , Gene Deletion , Genes, Bacterial/genetics , Humans , Ligases/deficiency , Ligases/metabolism , Melioidosis/microbiology , Melioidosis/pathology , Mice , Mice, Inbred BALB C , Virulence
15.
PLoS One ; 8(1): e55112, 2013.
Article in English | MEDLINE | ID: mdl-23383071

ABSTRACT

Many putative virulence factors of Burkholderia cenocepacia are controlled by various quorum sensing (QS) circuits. These QS systems either use N-acyl homoserine lactones (AHL) or cis-2-dodecenoic acid ("Burkholderia diffusible signal factor", BDSF) as signalling molecules. Previous work suggested that there is little cross-talk between both types of systems. We constructed mutants in B. cenocepacia strain J2315, in which genes encoding CepI (BCAM1870), CciI (BCAM0239a) and the BDSF synthase (BCAM0581) were inactivated, and also constructed double (ΔcepIΔBCAM0581, ΔcciIΔBCAM0581 and ΔcepIΔcciI) mutants and a triple (ΔcepIΔcciIΔBCAM0581) mutant. Subsequently we investigated phenotypic properties (antibiotic susceptibility, biofilm formation, production of AHL and BDSF, protease activity and virulence in Caenorhabditis elegans) and measured gene expression in these mutants, and this in the presence and absence of added BDSF, AHL or both. The triple mutant was significantly more affected in biofilm formation, antimicrobial susceptibility, virulence in C. elegans, and protease production than either the single or double mutants. The ΔBCAM0581 mutant and the ΔcepIΔBCAM0581 and ΔcciIΔBCAM0581 double mutants produced significantly less AHL compared to the WT strain and the ΔcepI and ΔcciI single mutant, respectively. The expression of cepI and cciI in ΔBCAM0581, was approximately 3-fold and 7-fold (p<0.05) lower than in the WT, respectively. The observed differences in AHL production, expression of cepI and cciI and QS-controlled phenotypes in the ΔBCAM0581 mutant could (at least partially) be restored by addition of BDSF. Our data suggest that, in B. cenocepacia J2315, AHL and BDSF-based QS systems co-regulate the same set of genes, regulate different sets of genes that are involved in the same phenotypes and/or that the BDSF system controls the AHL-based QS system. As the expression of the gene encoding the C6-HSL synthase CciI (and to a lesser extent the C8-HSL synthase CepI) is partially controlled by BDSF, it seems likely that the BDSF QS systems controls AHL production through this system.


Subject(s)
Acyl-Butyrolactones/metabolism , Burkholderia cenocepacia/cytology , Fatty Acids, Monounsaturated/metabolism , Genotype , Mutation , Phenotype , Quorum Sensing/genetics , Animals , Anti-Bacterial Agents/pharmacology , Biofilms/drug effects , Biofilms/growth & development , Burkholderia cenocepacia/drug effects , Burkholderia cenocepacia/genetics , Burkholderia cenocepacia/physiology , Caenorhabditis elegans/microbiology , Gene Deletion , Ligases/deficiency , Ligases/genetics , Quorum Sensing/drug effects
16.
Plant J ; 73(1): 91-104, 2013 Jan.
Article in English | MEDLINE | ID: mdl-22963672

ABSTRACT

Transpiration and gas exchange occur through stomata. Thus, the control of stomatal aperture is important for the efficiency and regulation of water use, and for the response to drought. Here, we demonstrate that SIZ1-mediated endogenous salicylic acid (SA) accumulation plays an important role in stomatal closure and drought tolerance. siz1 reduced stomatal apertures. The reduced stomatal apertures of siz1 were inhibited by the application of peroxidase inhibitors, salicylhydroxamic acid and azide, which inhibits SA-dependent reactive oxygen species (ROS) production, but not by an NADPH oxidase inhibitor, diphenyl iodonium chloride, which inhibits ABA-dependent ROS production. Furthermore, the introduction of nahG into siz1, which reduces SA accumulation, restored stomatal opening. Stomatal closure is generally induced by water deficit. The siz1 mutation caused drought tolerance, whereas nahG siz1 suppressed the tolerant phenotype. Drought stresses also induced expression of SA-responsive genes, such as PR1 and PR2. Furthermore, other SA-accumulating mutants, cpr5 and acd6, exhibited stomatal closure and drought tolerance, and nahG suppressed the phenotype of cpr5 and acd6, as did siz1 and nahG siz1. Together, these results suggest that SIZ1 negatively affects stomatal closure and drought tolerance through the accumulation of SA.


Subject(s)
Arabidopsis/physiology , Ligases/deficiency , Plant Growth Regulators/physiology , Plant Stomata/physiology , Reactive Oxygen Species/metabolism , Salicylic Acid/metabolism , Adaptation, Physiological/genetics , Adaptation, Physiological/physiology , Arabidopsis Proteins/genetics , Arabidopsis Proteins/physiology , Dehydration/physiopathology , Ligases/genetics , Ligases/physiology , Molecular Sequence Data
17.
Nature ; 474(7350): 173-8, 2011 May 25.
Article in English | MEDLINE | ID: mdl-21614000

ABSTRACT

Alternative splicing of pre-messenger RNAs diversifies gene products in eukaryotes and is guided by factors that enable spliceosomes to recognize particular splice sites. Here we report that alternative splicing of Saccharomyces cerevisiae SRC1 pre-mRNA is promoted by the conserved ubiquitin-like protein Hub1. Structural and biochemical data show that Hub1 binds non-covalently to a conserved element termed HIND, which is present in the spliceosomal protein Snu66 in yeast and mammals, and Prp38 in plants. Hub1 binding mildly alters spliceosomal protein interactions and barely affects general splicing in S. cerevisiae. However, spliceosomes that lack Hub1, or are defective in Hub1-HIND interaction, cannot use certain non-canonical 5' splice sites and are defective in alternative SRC1 splicing. Hub1 confers alternative splicing not only when bound to HIND, but also when experimentally fused to Snu66, Prp38, or even the core splicing factor Prp8. Our study indicates a novel mechanism for splice site utilization that is guided by non-covalent modification of the spliceosome by an unconventional ubiquitin-like modifier.


Subject(s)
Alternative Splicing , Gene Expression Regulation, Fungal , Ligases/metabolism , RNA Splice Sites/genetics , RNA, Fungal/genetics , Saccharomyces cerevisiae Proteins/metabolism , Saccharomyces cerevisiae/genetics , Saccharomyces cerevisiae/metabolism , Amino Acid Sequence , Binding Sites , Cell Line , Gene Deletion , Humans , Ligases/deficiency , Ligases/genetics , Membrane Proteins/genetics , Models, Molecular , Molecular Sequence Data , Nuclear Proteins/genetics , Protein Binding , Protein Conformation , RNA, Fungal/metabolism , RNA, Messenger/genetics , RNA, Messenger/metabolism , Ribonucleoprotein, U4-U6 Small Nuclear/deficiency , Ribonucleoprotein, U4-U6 Small Nuclear/genetics , Ribonucleoprotein, U5 Small Nuclear/deficiency , Ribonucleoprotein, U5 Small Nuclear/genetics , Ribonucleoproteins, Small Nuclear/chemistry , Ribonucleoproteins, Small Nuclear/deficiency , Ribonucleoproteins, Small Nuclear/genetics , Ribonucleoproteins, Small Nuclear/metabolism , Saccharomyces cerevisiae/chemistry , Saccharomyces cerevisiae Proteins/chemistry , Saccharomyces cerevisiae Proteins/genetics , Schizosaccharomyces/chemistry , Schizosaccharomyces/genetics , Schizosaccharomyces/metabolism , Schizosaccharomyces pombe Proteins/genetics , Schizosaccharomyces pombe Proteins/metabolism , Spliceosomes/chemistry , Spliceosomes/metabolism , Ubiquitin-Protein Ligase Complexes/deficiency , Ubiquitin-Protein Ligase Complexes/genetics , Ubiquitin-Protein Ligase Complexes/metabolism , Ubiquitins
18.
Mol Ther ; 19(5): 951-9, 2011 May.
Article in English | MEDLINE | ID: mdl-21364539

ABSTRACT

Optimization of the specific affinity of cardiac delivery vector could significantly improve the efficiency of gene/protein delivery, yet no cardiac vectors to date have sufficient target specificity for myocardial infarction (MI). In this study, we explored bacterial tropism for infarcted myocardium based on our previous observations that certain bacteria are capable of targeting the hypoxic regions in solid tumors. Out of several Escherichia coli or Salmonella typhimurium strains, the S. typhimurium defective in the synthesis of ppGpp (ΔppGpp S. typhimurium) revealed accumulation and selective proliferation in the infarcted myocardium without spillover to noncardiac tissue. The Salmonellae that were engineered to express a variant of Renilla luciferase gene (RLuc8), under the control of the E. coli arabinose operon promoter (P(BAD)), selectively targeted and delivered RLuc8 in the infarcted myocardium only upon injection of L-arabinose. An examination of the infarct size before and after infection, and estimations of C-reactive protein (CRP) and procalcitonin indicated that intravenous injection of ΔppGpp S. typhimurium did not induce serious local or systemic immune reactions. This current proof-of-principle study demonstrates for the first time the capacity of Salmonellae to target infarcted myocardium and to serve as a vehicle for the selective delivery of therapeutic agents in MI.


Subject(s)
Escherichia coli/isolation & purification , Heart/microbiology , Myocardial Infarction/genetics , Myocardial Infarction/microbiology , Salmonella typhimurium/isolation & purification , Animals , Arabinose/pharmacology , Blotting, Western , C-Reactive Protein/analysis , Ciprofloxacin/pharmacology , Disease Models, Animal , Drug Delivery Systems , Gene Expression , Gene Transfer Techniques , Genetic Therapy , Genetic Vectors , Ligases/deficiency , Ligases/genetics , Luciferases, Renilla/genetics , Luciferases, Renilla/metabolism , Male , Myocardial Infarction/pathology , Myocardial Infarction/therapy , Protein Engineering , Rats , Rats, Sprague-Dawley , Tropism
19.
BMC Mol Biol ; 9: 24, 2008 Feb 19.
Article in English | MEDLINE | ID: mdl-18284681

ABSTRACT

BACKGROUND: In yeast, DNA damage leads to the mono and polyubiquitination of the sliding clamp PCNA. Monoubiquitination of PCNA is controlled by RAD18 (E3 ligase) and RAD6 (E2 conjugating enzyme), while the extension of the monoubiquitinated PCNA into a polyubiquitinated substrate is governed by RAD5, and the heterodimer of UBC13/MMS2. Each modification directs a different branch of the DNA damage tolerance pathway (DDT). While PCNA monoubiquitination leads to error-prone bypass via TLS, biochemical studies have identified MMS2 along with its heteromeric partner UBC13 to govern the error-free repair of DNA lesions by catalyzing the formation of lysine 63-linked polyubiquitin chains (K63-polyUb). Recently, it was shown that PCNA polyubiquitination is conserved in human cells and that this modification is dependent on RAD18, UBC13 and SHPRH. However, the role of hMMS2 in this process was not specifically addressed. RESULTS: In this report we show that mammalian cells in which MMS2 was reduced by siRNA-mediated knockdown maintains PCNA polyubiquitination while a knockdown of RAD18 or UBC13 abrogates PCNA ubiquitination. Moreover, the additional knockdown of a UEV1A (MMS2 homolog) does not deplete PCNA polyubiquitination. Finally, mouse embryonic stem cells null for MMS2 with or without the additional depletion of mUEV1A continue to polyubiquitinated PCNA with normal kinetics. CONCLUSION: Our results point to a high level of redundancy in the DDT pathway and suggest the existence of another hMMS2 variant (hMMSv) or complex that can compensate for its loss.


Subject(s)
Ligases/metabolism , Polyubiquitin/metabolism , Proliferating Cell Nuclear Antigen/metabolism , Ubiquitination , Animals , DNA-Binding Proteins/metabolism , HeLa Cells , Humans , Ligases/deficiency , Mice , RNA, Small Interfering/metabolism , Stem Cells/metabolism , Stem Cells/radiation effects , Transcription Factors/metabolism , Ubiquitin-Conjugating Enzymes/deficiency , Ubiquitin-Conjugating Enzymes/metabolism , Ubiquitin-Protein Ligases , Ubiquitination/radiation effects , Ultraviolet Rays
20.
J Bacteriol ; 189(21): 7643-52, 2007 Nov.
Article in English | MEDLINE | ID: mdl-17766416

ABSTRACT

In this report, we investigate the link between nutrient limitation, RelA-mediated (p)ppGpp production, and virulence in the phytopathogen Erwinia carotovora subsp. atroseptica. A relA null mutant (JWC7) was constructed by allelic exchange, and we confirmed that, unlike the wild-type progenitor, this mutant did not produce elevated levels of (p)ppGpp upon nutrient downshift. However, (p)ppGpp production could be restored in strain JWC7 during nutrient limitation by supplying relA in trans. During growth on exoenzyme-inducing minimal medium, the relA mutant showed a diminution in secreted pectate lyase and protease activities and a severe defect in motility. The relA mutant was also impaired in its ability to cause rot in potato tubers. In the presence of serine hydroxamate (a competitive inhibitor of seryl tRNA synthase and a potent inducer of the stringent response in wild-type E. carotovora subsp. atroseptica), exoenzyme production was essentially abolished in JWC7 but could be restored in the presence of plasmid-borne relA. The inhibition of exoenzyme production in JWC7 caused by serine hydroxamate could not be overcome by addition of the quorum-sensing signal molecule, N-3-oxohexanoyl-l-homoserine lactone. Quantitative reverse transcription-PCR analysis of selected RNA species confirmed that the effects of relA on secreted pectate lyase activity and motility could be attributed to a reduction in transcription of the corresponding genes. We conclude that nutrient limitation is a potent environmental cue that triggers (p)ppGpp-dependent exoenzyme production in E. carotovora subsp. atroseptica. Furthermore, our data suggest that nutrient limitation [or rather, (p)ppGpp accumulation] is a prerequisite for effective quorum-sensing-dependent activation of exoenzyme production.


Subject(s)
Coenzymes/biosynthesis , Guanosine Tetraphosphate/metabolism , Ligases/metabolism , Pectobacterium carotovorum/enzymology , Bacterial Proteins/metabolism , Culture Media , DNA Primers , Genotype , Guanosine Tetraphosphate/biosynthesis , Kinetics , Ligases/deficiency , Ligases/genetics , Pectobacterium carotovorum/genetics , Pectobacterium carotovorum/growth & development , Polymerase Chain Reaction
SELECTION OF CITATIONS
SEARCH DETAIL